TWST - Twist Bioscience Corporation
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$64.40
DETAILS
HIGH:
$80.00
LOW:
$52.00
MEDIAN:
$65.00
CONSENSUS:
$64.40
UPSIDE:
6.32%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||
| Revenue | 376.6 | 313.0 | 245.1 | 203.6 | 132.3 | 90.1 | 54.4 | 25.4 | 10.8 | 2.3 |
| Cost of Revenue | 185.6 | 179.6 | 155.4 | 119.3 | 80.6 | 61.4 | 47.4 | 32.2 | 24.0 | 9.4 |
| Gross Profit | 191.0 | 133.3 | 89.7 | 84.2 | 51.7 | 28.7 | 7.0 | (6.8) | (13.3) | (7.2) |
| Operating Expenses | ||||||||||
| R&D Expenses | 80.3 | 90.9 | 106.9 | 120.3 | 69.1 | 43.0 | 35.7 | 20.3 | 19.2 | 18.2 |
| SG&A Expenses | 247.0 | 218.4 | 189.7 | 212.9 | 135.9 | 103.3 | 80.1 | 43.5 | 26.1 | 18.3 |
| Other Expenses | 0 | 44.9 | 10.3 | (14.2) | (0.5) | 22.5 | (0.3) | (0.1) | (0.1) | 0.1 |
| Operating Expenses | 327.3 | 354.2 | 306.9 | 319.0 | 204.4 | 168.8 | 115.8 | 63.8 | 45.2 | 36.5 |
| Operating Income | ||||||||||
| Operating Income | (136.3) | (220.8) | (217.2) | (234.8) | (152.7) | (140.1) | (108.8) | (70.6) | (58.5) | (43.7) |
| Interest Expense | 0 | 0.0 | 0.0 | 0.1 | 0.4 | 0.8 | 1.3 | 1.3 | 0.9 | 0.7 |
| Interest Income | 11.4 | 15.3 | 14.4 | 3.1 | 0.4 | 1.5 | 3.0 | 1.0 | 0.4 | 0.2 |
| Profitability | ||||||||||
| EBITDA | (52.1) | (176.7) | (174.2) | (211.7) | (143.9) | (132.1) | (99.8) | (64.0) | (53.1) | (39.1) |
| EBIT | (77.0) | (208.1) | (203.5) | (228.2) | (153.7) | (138.8) | (106.1) | (69.7) | (58.1) | (43.3) |
| Income Before Tax | (77.0) | (208.2) | (203.5) | (228.3) | (154.0) | (139.5) | (107.4) | (71.0) | (59.0) | (44.1) |
| Income Tax Expense | 0.7 | 0.6 | 1.2 | (10.4) | (1.9) | 0.4 | 0.3 | 0.2 | 0.3 | 0 |
| Net Income | (77.7) | (208.7) | (204.6) | (217.9) | (152.1) | (139.9) | (107.7) | (71.2) | (59.3) | (44.1) |
| Per Share Data | ||||||||||
| EPS (Basic) | -1.30 | -3.60 | -3.60 | -4.04 | -3.15 | -3.57 | -3.92 | -2.68 | -3.16 | -2.35 |
| EPS (Diluted) | -1.30 | -3.60 | -3.60 | -4.04 | -3.15 | -3.57 | -3.92 | -2.68 | -3.16 | -2.35 |
| Shares Outstanding | 59.8 | 58.0 | 56.9 | 53.9 | 48.3 | 39.2 | 27.5 | 26.6 | 18.8 | 18.8 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash & Cash Equivalents | 183.0 | 226.3 | 286.5 | 378.7 | 465.8 | 93.7 | 46.7 | 80.8 | 31.2 | 28.6 |
| Short-Term Investments | 49.4 | 50.1 | 49.9 | 126.3 | 12.0 | 196.3 | 91.4 | 0 | 31.0 | 27.3 |
| Net Receivables | 57.0 | 34.9 | 44.1 | 40.3 | 28.5 | 25.4 | 12.1 | 5.4 | 2.3 | 0.7 |
| Inventory | 28.3 | 24.1 | 32.1 | 39.3 | 31.8 | 12.3 | 7.3 | 6.0 | 1.8 | 1.2 |
| Other Current Assets | 0 | 11.4 | 11.7 | 0 | 0 | 1.0 | 0 | 3.5 | 0 | 0 |
| Total Current Assets | 333.0 | 346.8 | 424.3 | 596.5 | 546.5 | 334.9 | 160.1 | 95.7 | 67.9 | 59.0 |
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment | 151.7 | 161.3 | 203.4 | 214.4 | 105.7 | 59.2 | 20.8 | 12.3 | 14.8 | 14.6 |
| Goodwill | 82.2 | 85.8 | 85.8 | 85.8 | 22.4 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 |
| Intangible Assets | 13.4 | 14.5 | 54.5 | 59.7 | 18.3 | 0.3 | 0.5 | 0.7 | 0.9 | 1.1 |
| Long-Term Investments | 54.3 | 0 | 0 | 0 | 0 | 0 | 0.6 | 0.6 | 0.2 | 0.3 |
| Other Non-Current Assets | 7.3 | 5.9 | 8.5 | 5.0 | 9.2 | 3.4 | 4.4 | 5.9 | 0.9 | 0.5 |
| Total Non-Current Assets | 308.9 | 267.5 | 352.1 | 364.9 | 155.6 | 64.0 | 26.9 | 20.1 | 17.8 | 17.4 |
| Total Assets | 641.9 | 614.3 | 776.4 | 961.4 | 702.1 | 398.9 | 187.0 | 115.8 | 85.7 | 76.5 |
| Current Liabilities | ||||||||||
| Account Payables | 11.1 | 1.6 | 14.1 | 20.1 | 14.9 | 4.8 | 9.8 | 7.5 | 2.8 | 2.3 |
| Short-Term Debt | 13.8 | 0 | 0 | 0 | 1.6 | 3.3 | 3.3 | 2.5 | 0 | 1.4 |
| Deferred Revenue | 6.9 | 2.1 | 0 | 3.5 | 1.1 | 0 | 16.4 | 7.6 | 0 | 4.6 |
| Other Current Liabilities | 23.8 | 34.6 | 18.6 | 39.6 | 28.4 | 2.6 | 0.8 | 3.1 | 3.2 | 0.4 |
| Total Current Liabilities | 91.4 | 71.0 | 73.3 | 90.7 | 63.1 | 36.0 | 30.4 | 18.5 | 9.5 | 8.7 |
| Non-Current Liabilities | ||||||||||
| Long-Term Debt | 61.8 | 0 | 0 | 0 | 0 | 1.4 | 4.4 | 7.2 | 9.2 | 9.8 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | (46.0) | 0.4 | 0.5 | 0.1 | 5.1 | 0.4 | 0.2 | 291.5 | 200.4 | 134.6 |
| Total Non-Current Liabilities | 77.5 | 70.6 | 79.6 | 81.3 | 58.2 | 26.6 | 4.6 | 298.7 | 209.5 | 144.4 |
| Total Liabilities | 168.9 | 141.6 | 153.0 | 172.0 | 121.3 | 62.6 | 34.9 | 317.2 | 219.0 | 153.1 |
| Stockholders' Equity | ||||||||||
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | (1,319.6) | (1,241.9) | (1,033.0) | (828.4) | (610.6) | (458.5) | (318.5) | (210.9) | (139.6) | (80.3) |
| Accumulated Other Comprehensive Income | (0.6) | (0.5) | (0.8) | (1.8) | 0.5 | 0.1 | 0.2 | 0.1 | 0.0 | 0.0 |
| Total Stockholders' Equity | 473.0 | 472.7 | 623.4 | 789.4 | 580.8 | 336.3 | 152.1 | (201.4) | (133.4) | (76.6) |
| Total Liabilities & Equity | 641.9 | 614.3 | 776.4 | 961.4 | 702.1 | 398.9 | 187.0 | 115.8 | 85.7 | 76.5 |
| Debt Metrics | ||||||||||
| Total Debt | 137.3 | 85.0 | 94.1 | 94.9 | 62.9 | 36.0 | 7.7 | 9.7 | 9.2 | 11.2 |
| Net Debt | (45.7) | (141.3) | (192.4) | (283.8) | (402.9) | (57.7) | (39.0) | (71.0) | (22.1) | (17.4) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | (77.7) | (208.7) | (204.6) | (217.9) | (152.1) | (139.9) | (107.7) | (71.2) | (59.3) | (44.1) |
| Depreciation & Amortization | 24.9 | 31.4 | 29.3 | 16.5 | 9.8 | 6.7 | 6.1 | 5.7 | 5.0 | 4.2 |
| Stock-Based Compensation | 64.5 | 50.9 | 30.3 | 79.7 | 37.0 | 17.1 | 11.2 | 3.0 | 1.9 | 0.9 |
| Change in Working Capital | (12.6) | 15.4 | (1.0) | (5.4) | (9.4) | (25.2) | 3.0 | (4.2) | (0.1) | 0.2 |
| Other Non-Cash Items | (46.7) | 46.9 | 4.0 | 2.7 | 2.5 | (0.7) | 0.5 | 0.6 | 0.5 | 0.2 |
| Operating Cash Flow | (47.6) | (64.1) | (142.5) | (124.4) | (112.2) | (142.3) | (87.9) | (66.2) | (51.3) | (38.6) |
| Investing Activities | ||||||||||
| Capital Expenditure | (28.0) | (5.1) | (27.8) | (101.9) | (27.1) | (9.9) | (14.8) | (3.7) | (6.6) | (6.2) |
| Acquisitions | 2.5 | 0 | 5.9 | (8.2) | (0.5) | 104.8 | 0.0 | 0.0 | 0.3 | 0.3 |
| Purchases of Investments | (49.4) | (51.9) | (76.3) | (217.6) | (58.8) | (202.9) | (177.6) | (3.5) | (40.6) | (27.3) |
| Sales/Maturities of Investments | 50.1 | 53.9 | 154.7 | 100.5 | 242.5 | 98.1 | 87.5 | 34.5 | 36.9 | 0 |
| Other Investing Activities | 0 | 0 | (5.9) | (5.8) | 0 | (104.8) | (90.1) | (0.4) | 0.1 | 0.2 |
| Investing Cash Flow | (24.8) | (3.1) | 50.6 | (232.9) | 156.2 | (114.7) | (104.8) | 26.9 | (9.9) | (33.3) |
| Financing Activities | ||||||||||
| Net Debt Issuance | 0 | 0 | 0 | (1.6) | (3.3) | (3.3) | (2.5) | 0 | (2.0) | 7.2 |
| Stock Repurchased | (0.0) | (4.0) | (4.4) | (7.8) | (10.8) | (2.4) | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 15 | 10.9 | 5.3 | 10.0 | 19.5 | 13.9 | 4.9 | (2.0) | 0.2 | 62.4 |
| Financing Cash Flow | 28.5 | 6.9 | 0.9 | 270.5 | 329.2 | 303.7 | 158.6 | 88.8 | 63.8 | 69.6 |
| Cash Position | ||||||||||
| Net Change in Cash | (43.3) | (60.1) | (91.0) | (87.1) | 373.1 | 46.8 | (34.1) | 49.5 | 2.6 | (2.3) |
| Cash at Beginning | 226.3 | 289.3 | 380.3 | 467.4 | 94.2 | 47.4 | 81.5 | 31.2 | 28.6 | 30.9 |
| Cash at End | 183.0 | 229.1 | 289.3 | 380.3 | 467.4 | 94.2 | 47.4 | 80.8 | 31.2 | 28.6 |
| Free Cash Flow | (75.6) | (69.2) | (170.3) | (226.2) | (139.3) | (152.1) | (102.7) | (69.9) | (57.9) | (44.8) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 376.6 | 313.0 | 245.1 | 203.6 | 132.3 | 90.1 | 54.4 | 25.4 | 10.8 | 2.3 |
| Gross Profit | 191.0 | 133.3 | 89.7 | 84.2 | 51.7 | 28.7 | 7.0 | (6.8) | (13.3) | (7.2) |
| Operating Income | (136.3) | (220.8) | (217.2) | (234.8) | (152.7) | (140.1) | (108.8) | (70.6) | (58.5) | (43.7) |
| Net Income | (77.7) | (208.7) | (204.6) | (217.9) | (152.1) | (139.9) | (107.7) | (71.2) | (59.3) | (44.1) |
| EPS (Diluted) | -1.30 | -3.60 | -3.60 | -4.04 | -3.15 | -3.57 | -3.92 | -2.68 | -3.16 | -2.35 |
| Balance Sheet | ||||||||||
| Cash & Equivalents | 183.0 | 226.3 | 286.5 | 378.7 | 465.8 | 93.7 | 46.7 | 80.8 | 31.2 | 28.6 |
| Total Assets | 641.9 | 614.3 | 776.4 | 961.4 | 702.1 | 398.9 | 187.0 | 115.8 | 85.7 | 76.5 |
| Total Debt | 137.3 | 85.0 | 94.1 | 94.9 | 62.9 | 36.0 | 7.7 | 9.7 | 9.2 | 11.2 |
| Stockholders' Equity | 473.0 | 472.7 | 623.4 | 789.4 | 580.8 | 336.3 | 152.1 | (201.4) | (133.4) | (76.6) |
| Cash Flow | ||||||||||
| Operating Cash Flow | (47.6) | (64.1) | (142.5) | (124.4) | (112.2) | (142.3) | (87.9) | (66.2) | (51.3) | (38.6) |
| Capital Expenditure | (28.0) | (5.1) | (27.8) | (101.9) | (27.1) | (9.9) | (14.8) | (3.7) | (6.6) | (6.2) |
| Free Cash Flow | (75.6) | (69.2) | (170.3) | (226.2) | (139.3) | (152.1) | (102.7) | (69.9) | (57.9) | (44.8) |